Nasacort Allergy 24HR

Manufacturer: Chattem, Inc.
Effective date: 2026-01-14
Label type: HUMAN OTC DRUG LABEL
Version: 38
Source: full-release
Hydrated at: 2026-06-01 01:32:35

Label at a glance#

ProductNasacort Allergy 24HR

Active ingredientTRIAMCINOLONE ACETONIDE

Label structure12 sections

Indications and uses

temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose

Dosage and administration

Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per da...

Contacts and useful links#

PhoneLabel contact1-800-633-1610

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Nasacort Allergy 24HR

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each spray)

Triamcinolone acetonide

55 mcg (glucocorticoid)

Purpose

OTC - PURPOSE SECTION

Allergy symptom reliever

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms of hay fever or other upper
respiratory allergies:

nasal congestion
runny nose
sneezing
itchy nose

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

in children under 2 years of age
if you have ever had an allergic reaction to any of the ingredients

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

have had recent nose ulcers or nose surgery
have had a nose injury that has not healed
are using a steroid medicine for asthma, allergies or skin rash
have an eye infection
have or had glaucoma or cataracts

When using this product

OTC - WHEN USING SECTION

the growth rate of some children may be slower
some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief.
do not share this bottle with anyone else as this may spread germs
remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have, or come into contact with someone who has, chickenpox, measles or tuberculosis
you have or develop symptoms of an infection such as a persistent fever
you have any change in vision
you have severe or frequent nosebleeds

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Read insert (inside package) on how to:

get a new bottle ready (primed) before first use
prime bottle again if not used for more than 2 weeks
use the spray
clean the spray nozzle

ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
adults and children 12 years of age and older	once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day
CHILDREN 2 TO UNDER 12 YEARS OF AGE
the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year.
children 6 to under 12 years of age	an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day.
children 2 to under 6 years of age	an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently
children under 2 years of age	do not use

do not use more than directed
if you forget a dose, do not double the next dose
do not spray into eyes or mouth
if allergy symptoms do not improve after one week, stop using and talk to a doctor
do not use for the common cold
shake well before each use

Other information

SPL UNCLASSIFIED SECTION

do not use if sealed package is torn or opened
keep package and insert. They contain important information.
store between 20°- 25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, carboxymethylcellulose sodium, dextrose, edetate disodium, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

Questions or comments?

OTC - QUESTIONS SECTION

call toll-free 1-800-633-1610

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 41167-5800-3
Multi-Symptom
Nasal Allergy Spray
Nasacort
Allergy 24HR
triamcinolone acetonide nasal spray 55 mcg per spray
allergy symptom reliever
(glucocorticoid)*
0.37 fl. oz. (10.8 ml) 60 Sprays

*Triamcinolone acetonide
is a steroid medicine
known as a glucocorticoid.

Principal Display Panel NDC 41167-5800-3 Multi-Symptom Nasal Allergy Spray Nasacort Allergy 24HR triamcinolone acetonide nasal spray 55 mcg per spray allergy symptom reliever (g...

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Original Prescription Strength
NDC 41167-5800-5
Multi-Symptom
Nasal Allergy Spray
Nasacort
Allergy 24HR
triamcinolone acetonide nasal spray 55 mcg per spray
allergy symptom reliever
(glucocorticoid)*
0.57 fl. oz. (16.9 ml) 120 Sprays

*Triamcinolone acetonide
is a steroid medicine
known as a glucocorticoid.

Principal Display Panel Original Prescription Strength NDC 41167-5800-5 Multi-Symptom Nasal Allergy Spray Nasacort Allergy 24HR triamcinolone acetonide nasal spray 55 mcg per sp...

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nasacort Allergy 24HR
Multi-Symptom
Nasal Allergy Spray
Insert

Principal Display Panel Nasacort Allergy 24HR Multi-Symptom Nasal Allergy Spray Insert

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1797915	Nasacort 55 MCG/ACTUAT Metered Dose Nasal Spray	PSN	38
1797913	triamcinolone acetonide 55 MCG/ACTUAT Metered Dose Nasal Spray	PSN	38
1797915	triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray [Nasacort]	SBD	38
1797913	triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray	SCD	38
1797915	Nasacort 0.055 MG/ACTUAT Metered Dose Nasal Spray	SY	38
1797915	Nasacort 55 MCG/ACTUAT Metered Dose Nasal Spray	SY	38
1797913	triamcinolone acetonide 55 MCG/ACTUAT Metered Dose Nasal Spray	SY	38

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TRIAMCINOLONE ACETONIDE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d4d7da1a-7fd4-628e-cdae-89e749b1c534	Product name	7	20260127
75f7e47b-8736-a182-fc44-22aca8d79689	Product name	2	20251211
62986c8d-91f1-b1ba-b5a3-8b54b75bb8c2	Product name	6	20250516
e42f429b-c4e5-0402-e1c5-730154df4060	Product name	4	20240205
38d4de13-64b3-4057-b91c-4b5126962341	Product name	1	20220516
089e0644-1ea8-8654-4113-39f960dd57d5	Product name	3	20210115
1629e00f-54fb-4a43-8306-b58442b23902	Product name	9	20200430
5331c9c8-f64b-11e6-ccf1-071c477fcb0b	Product name	7	20190612
9f64e0dc-109c-9660-8e0e-91ec987b3817	Product name	6	20171204
dfa879a3-32de-49f0-a7ba-9b9c3e13002f	Product name	1	20171204
8de20f81-8411-4cf1-a8b2-03404ee56d01	Product name	3	20171109
a5f1a68c-0352-4f34-46a3-9b4eed239ed8	Product name	2	20160819
355b2224-0895-7135-83f5-d099a6a82a0a	Product name	1	20140508
55be6b50-8cc0-f0f1-74a1-3416a91193aa	Product name	1	20140508
7a0092d1-1e8c-0d78-4f8d-d95fa15cc3cf	Product name	1	20140508
89b93c13-4be8-69f3-b33b-63e64feffb9b	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
41167-5800-1	Nasacort Allergy 24HR	30 in 1 BOTTLE, SPRAY	SPRAY, METERED	30	38
41167-5800-1	Nasacort Allergy 24HR	1 in 1 CARTON	SPRAY, METERED	1	38
41167-5800-2	Nasacort Allergy 24HR	120 in 1 BOTTLE, SPRAY	SPRAY, METERED	120	38
41167-5800-2	Nasacort Allergy 24HR	2 in 1 CARTON	SPRAY, METERED	2	38
41167-5800-3	Nasacort Allergy 24HR	1 in 1 CARTON	SPRAY, METERED	1	38
41167-5800-3	Nasacort Allergy 24HR	60 in 1 BOTTLE, SPRAY	SPRAY, METERED	60	38
41167-5800-5	Nasacort Allergy 24HR	120 in 1 BOTTLE, SPRAY	SPRAY, METERED	120	38
41167-5800-5	Nasacort Allergy 24HR	1 in 1 CARTON	SPRAY, METERED	1	38
41167-5800-6	Nasacort Allergy 24HR	120 in 1 BOTTLE, SPRAY	SPRAY, METERED	120	38
41167-5800-6	Nasacort Allergy 24HR	4 in 1 CARTON	SPRAY, METERED	4	38
41167-5800-7	Nasacort Allergy 24HR	120 in 1 BOTTLE, SPRAY	SPRAY, METERED	120	38
41167-5800-7	Nasacort Allergy 24HR	3 in 1 CARTON	SPRAY, METERED	3	38

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
41167-5800-1	ML - Milliliter	41167-5800	9958a2e4-7604-4dbb-a4ee-8e22e9e8407a	1	2021-09-07
41167-5800-2	ML - Milliliter	41167-5800	342bc137-adff-40de-9b66-840c2e732971	1	2018-03-08
41167-5800-3	ML - Milliliter	41167-5800	8f72ef2f-97b1-4664-ba18-048b269d75a7	1	2014-04-03
41167-5800-5	ML - Milliliter	41167-5800	ccdd9126-e3ee-4384-8ce8-a056ea3ad67c	1	2014-04-03
41167-5800-7	ML - Milliliter	41167-5800	a5563c64-06d9-4af0-9e21-f5604c1b6e8c	1	2014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TRIAMCINOLONE ACETONIDE	ACTIVE INGREDIENT	F446C597KA	19
TRIAMCINOLONE ACETONIDE	ACTIVE MOIETY	F446C597KA	19
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	19
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	INACTIVE INGREDIENT	K679OBS311	19
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	19
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	19
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	19
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	19
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	19
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	19
WATER	INACTIVE INGREDIENT	059QF0KO0R	19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Nasacort Allergy 24HR
Triamcinolone Acetonide
CELLULOSE, MICROCRYSTALLINE
CARBOXYMETHYLCELLULOSE SODIUM
POLYSORBATE 80
DEXTROSE
BENZALKONIUM CHLORIDE
EDETATE DISODIUM
HYDROCHLORIC ACID
SODIUM HYDROXIDE
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
41167-5800	41167-5800-7, 41167-5800-3, 41167-5800-5, 41167-5800-2, 41167-5800-1, 41167-5800-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TRIAMCINOLONE ACETONIDE	F446C597KA	ACTIB
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT
DEXTROSE	IY9XDZ35W2	IACT
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
WATER	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 546 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	POWDER, FOR SUSPENSION / INTRAMUSCULAR	0.7 %w/v		Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, EXTENDED RELEASE / ORAL		1246 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FOR SUSPENSION / ORAL		20100 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY, METERED / NASAL	ADJ PH		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SUSPENSION/ DROPS / ORAL	12.85 mg/2.5ml		Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, DELAYED RELEASE / ORAL		366 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, SUSPENSION / INTRAMUSCULAR		30 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE / ORAL		29520 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY, METERED / NASAL	ADJ PH		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		1576 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / BUCCAL		18 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, EXTENDED RELEASE / ORAL		1246 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE / ORAL		29520 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TROCHE / ORAL		300 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	LOTION / TOPICAL	NA		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SYSTEM / TOPICAL		1680 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SPRAY, METERED / NASAL		4 mg	Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, SUSPENSION / SOFT TISSUE		15 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		25 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, SUSPENSION / INTRAVITREAL	0.5 %w/v		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET, EXTENDED RELEASE / ORAL		933 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SYSTEM / TOPICAL		1680 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	LOTION / TOPICAL	NA		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, SUSPENSION / INTRA-ARTICULAR		30 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SPRAY, METERED / NASAL	0.1 mg/1ml		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	SUSPENSION, EXTENDED RELEASE / ORAL		1120 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	CAPSULE, DELAYED RELEASE / ORAL	4.2 mg		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET / ORAL		280 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SPRAY, METERED / NASAL	0.1 mg/1ml		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	POWDER, FOR SUSPENSION / ORAL		560 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SPRAY, METERED / NASAL		1 mg	Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SUSPENSION / ENTERAL		2920 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / BUCCAL		18 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	CAPSULE, DELAYED RELEASE / ORAL	4.2 mg		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET / BUCCAL	4 mg		Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION / INTRAMUSCULAR		30 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET / ORAL		280 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	TABLET, DELAYED RELEASE / ORAL		280 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	PASTE / DENTAL		249 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TROCHE / ORAL		300 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY, METERED / NASAL	ADJ PH		Exact identifier — unii+route+dosage form 7 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		615 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR		25 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	FILM / BUCCAL		18 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	SYRUP / ORAL	26.5 mg		Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	CAPSULE, EXTENDED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	PASTE / DENTAL		249 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, SUSPENSION / INTRA-ARTICULAR		30 mg	Exact identifier — unii candidate 308 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	POWDER, FOR SUSPENSION / ORAL		4441 mg	Exact identifier — unii candidate 196 equally ranked IID candidates
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM	CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		25 mg	Exact identifier — unii candidate 308 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020468-002	NASACORT ALLERGY 24 HOUR	TRIAMCINOLONE ACETONIDE	0.055MG/SPRAY	SPRAY, METERED / NASAL		RLD, RS	2013-10-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020468-002	NASACORT ALLERGY 24 HOUR	0.055MG/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2013-10-11	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nasacort Allergy 24HR	TRIAMCINOLONE ACETONIDE	Chattem, Inc.	4bff57a5-cce0-401c-a0fe-23c65c1b7ddc	2026-01-14	Warnings	Exact identifier ndc (package): 41167-5800-7 ndc (package): 41167-5800-3 ndc (package): 41167-5800-6 ndc (package): 41167-5800-5 ndc (package): 41167-5800-2 ndc (package): 41167-5800-1 ndc (product): 41167-5800 ndc11 (package): 41167580006 ndc11 (package): 41167580003 ndc11 (package): 41167580005 ndc11 (package): 41167580002 ndc11 (package): 41167580007 ndc11 (package): 41167580001 spl id: 153d24d7-d4ba-4bde-b379-6c0244482738 spl set id: 4bff57a5-cce0-401c-a0fe-23c65c1b7ddc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.